A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution.
A mechanistic pharmacokinetic model to assess modified oral drug bioavailability after surgery in morbidly obese patients: interaction between CYP3A gut wall metabolism, permeability and dissolution.